Thus, when Bcl-XL was inhibited to bind and repress Bim, in conjunction with direct MEK inhibition, it led to significant apoptosis in many KRAS mutant cell lines from varying origins and caused tumor regression [89]. Here, BCL2L11 is linked to neoplasm.